Literature DB >> 14973103

Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk.

Andrew Poullis1, Russell Foster, Ajeya Shetty, Magne K Fagerhol, Michael A Mendall.   

Abstract

The mechanisms by which the lifestyle risk factors obesity, physical inactivity, and low fiber intake predispose to colorectal cancer (CRC) are unclear. Chronic bowel inflammation predisposes to malignancy in cases of inflammatory bowel disease. Many lifestyle risk factors for CRC are associated with evidence of systemic inflammation as indicated by circulating levels of C-reactive protein (CRP), but it is unknown how this relates to inflammation at tissue level. Little is known about the degree of bowel inflammation in general population and the factors that affect it. Therefore, we aimed to assess the relation of levels of bowel inflammation in the general population and lifestyle risk factors for CRC, and to additionally assess whether these associations, if present, were attenuated by controlling for evidence of systemic inflammation. Average CRC risk subjects (320) of either sex aged 50-70 were recruited in South London. A stool sample was provided for calprotectin measurement (a marker of bowel inflammation), serum for CRP, and a detailed dietary and lifestyle questionnaire completed. There was a significant positive relationship between fecal calprotectin and increasing age (P = 0.002), obesity (P = 0.04), physical inactivity (P = 0.01), and an inverse relationship with fiber intake (P = 0.02) and vegetable consumption (P = 0.04). The relationship with obesity was attenuated by controlling for serum CRP. Fecal calprotectin levels are associated with lifestyle risk factors for colorectal cancer. Low-level asymptomatic bowel inflammation may be the link between lifestyle and the pathogenesis of CRC, and circulating proinflammatory cytokines may be part of the mechanism for this link.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14973103     DOI: 10.1158/1055-9965.epi-03-0160

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  56 in total

Review 1.  Adipose tissue and inflammatory bowel disease pathogenesis.

Authors:  Christopher Fink; Iordanes Karagiannides; Kyriaki Bakirtzi; Charalabos Pothoulakis
Journal:  Inflamm Bowel Dis       Date:  2012-03-08       Impact factor: 5.325

2.  Chronic subclinical bowel inflammation may explain increased risk of colorectal cancer in obese people.

Authors:  Biku J John; Al Mutaz Abulafi; Andrew Poullis; Michael Anthony Mendall
Journal:  Gut       Date:  2007-07       Impact factor: 23.059

Review 3.  Gastrointestinal Complications of Obesity.

Authors:  Michael Camilleri; Harmeet Malhi; Andres Acosta
Journal:  Gastroenterology       Date:  2017-02-10       Impact factor: 22.682

4.  Is obesity a risk factor for Crohn's disease?

Authors:  Michael A Mendall; A Viran Gunasekera; B Joseph John; Devinder Kumar
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

Review 5.  Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.

Authors:  Masakazu Yashiro
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

Review 6.  Roles of hormones and signaling molecules in describing the relationship between obesity and colon cancer.

Authors:  Angelos K Sikalidis; Behzad Varamini
Journal:  Pathol Oncol Res       Date:  2011-01-09       Impact factor: 3.201

7.  Measures of obesity and risk of Crohn's disease and ulcerative colitis.

Authors:  Hamed Khalili; Ashwin N Ananthakrishnan; Gauree G Konijeti; Leslie M Higuchi; Charles S Fuchs; James M Richter; Andrew T Chan
Journal:  Inflamm Bowel Dis       Date:  2015-02       Impact factor: 5.325

8.  The association between circulating high-sensitivity C-reactive protein concentration and pathologic measures of colonic inflammation.

Authors:  Corinne E Joshu; Kostantinos K Tsilidis; Sarah B Peskoe; Francis M Giardiello; Paul J Dluzniewski; William G Nelson; Christine A Iacobuzio-Donahue; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2014-01-17       Impact factor: 2.506

Review 9.  Physical activity before and after diagnosis of colorectal cancer: disease risk, clinical outcomes, response pathways and biomarkers.

Authors:  David J Harriss; N Tim Cable; Keith George; Thomas Reilly; Andrew G Renehan; Najib Haboubi
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

10.  Evaluation of specific fecal protein biochips for the diagnosis of colorectal cancer.

Authors:  Hui-Peng Wang; Yang-Yun Wang; Jie Pan; Rong Cen; Yuan-Kun Cai
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.